English, PDF, 682kb
From alternative protein sources to rapid vaccine development, synthetic biology can address global challenges and transform industries. But are current governance frameworks up to the task?
Russia’s large-scale aggression is aggravating the long-term trend of underinvestment in R&D in Ukraine through direct war-related destruction of physical infrastructure and human capital, as well as accelerated brain drain. About a quarter of the research workforce had left the country as of August 2022.
Factors shaping the future of STI include the unequal effects of the COVID-19 crisis on R&D across sectors, the accelerated adoption of digital tools and techniques, and changes in the openness, inclusiveness and agility of research and innovation ecosystems.
Factors shaping the future of STI include the unequal effects of the pandemic on R&D across sectors, the accelerated adoption of digital tools and techniques, and changes in the openness, inclusiveness and agility of research and innovation ecosystems.
This brief discusses the obstacles in developing international clinical trials that are critical to fight the COVID-19 pandemic. It provides information on relevant adaptations of regulatory requirements for clinical trials intended to accelerate processes, and highlights the need to further harmonise these regulations between national regulatory authorities.
The recent growth in the space sector has generated unprecedented levels of entrepreneurship and start-up activity, but the COVID-19 crisis could reverse this positive trend. Space agencies and other public administrations therefore need to fully consider vulnerable smaller actors in their overall crisis responses.
The urgency of tackling COVID-19 has led governments in many countries to launch a number of short-notice and fast-tracked initiatives. Yet without proper co-ordination amongst ministries and agencies, they run the risk of duplicating efforts or missing opportunities, resulting in slower progress and economic inefficiencies.
Governments can deploy non-traditional approaches to science, technology and innovation policy making that draw on society’s collective intelligence to find solutions to the COVID-19 crisis. Tools such as innovation prizes, prediction markets, and open-source solutions have shown value and are well-suited to immediately respond to the crisis.
In global emergencies like the COVID-19 pandemic, open science policies can remove obstacles to the free flow of research data and ideas, and thus accelerate the pace of research critical to combating the disease.
While individual experts are often responsible for communicating science advice, they must be guided by clear common principles and supported by scientific institutions and networks across the globe. This requires international co-operation and open sharing of data and information.